- Home
- BYFC vs SRZN Comparison
BYFC vs SRZN Comparison
Compare BYFC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- SRZN
- Stock Information
- Founded
- BYFC 1946
- SRZN 2015
- Country
- BYFC United States
- SRZN United States
- Employees
- BYFC N/A
- SRZN N/A
- Industry
- BYFC Savings Institutions
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- BYFC Finance
- SRZN Health Care
- Exchange
- BYFC Nasdaq
- SRZN Nasdaq
- Market Cap
- BYFC 63.8M
- SRZN 72.8M
- IPO Year
- BYFC 1996
- SRZN N/A
- Fundamental
- Price
- BYFC $6.20
- SRZN $10.00
- Analyst Decision
- BYFC
- SRZN Strong Buy
- Analyst Count
- BYFC 0
- SRZN 2
- Target Price
- BYFC N/A
- SRZN $38.50
- AVG Volume (30 Days)
- BYFC 3.8K
- SRZN 15.0K
- Earning Date
- BYFC 07-29-2025
- SRZN 08-11-2025
- Dividend Yield
- BYFC N/A
- SRZN N/A
- EPS Growth
- BYFC N/A
- SRZN N/A
- EPS
- BYFC N/A
- SRZN N/A
- Revenue
- BYFC $32,732,999.00
- SRZN $11,638,000.00
- Revenue This Year
- BYFC N/A
- SRZN N/A
- Revenue Next Year
- BYFC N/A
- SRZN N/A
- P/E Ratio
- BYFC N/A
- SRZN N/A
- Revenue Growth
- BYFC N/A
- SRZN N/A
- 52 Week Low
- BYFC $4.68
- SRZN $5.90
- 52 Week High
- BYFC $9.46
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- BYFC 38.34
- SRZN 61.67
- Support Level
- BYFC $6.00
- SRZN $9.15
- Resistance Level
- BYFC $6.68
- SRZN $10.05
- Average True Range (ATR)
- BYFC 0.14
- SRZN 0.53
- MACD
- BYFC -0.01
- SRZN 0.20
- Stochastic Oscillator
- BYFC 0.00
- SRZN 93.33
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).